GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹269 Cr | ₹320 Cr | ₹3.82 Cr | ₹3.93 Cr | ₹4.07 Cr |
What is the latest Total Debt ratio of GLAND PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹269 Cr |
| Mar2024 | ₹320 Cr |
| Mar2023 | ₹3.82 Cr |
| Mar2022 | ₹3.93 Cr |
| Mar2021 | ₹4.07 Cr |
How is Total Debt of GLAND PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹269 Cr | -15.81 | |
| Mar2024 | ₹320 Cr | 8,269.07 | |
| Mar2023 | ₹3.82 Cr | -2.85 | |
| Mar2022 | ₹3.93 Cr | -3.34 | |
| Mar2021 | ₹4.07 Cr | - | |
Compare Total Debt of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹40,652.7 Cr | -0.2% | 10% | 31.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -0.2% |
10% |
31.2% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses